Piotroski F-score
Failed
1 check could not be answered: a figure either filed year needs is missing, not evidence either way.
BNGO reported revenue of $28.51M and net income of −$26.4M in FY2025.
| Fiscal year | Revenue | Net income |
|---|---|---|
| 2025 | $28.51M | −$26.4M |
| 2024 | $30.78M | −$112.02M |
| 2023 | $36.12M | −$232.49M |
6 more years are on Measure
Free, no card, and it does not expire. See what the paid plans add
Also filed under Medical Instruments & Supplies, ranked by how closely they sit beside BNGO.
The assistant answers from what BNGO has actually filed: 9 annual reports filed with the SEC and 11 Form 4 filings from the last year. Every figure in a reply links to the filing it came from, so an answer can be checked rather than believed.
Press one and the answer appears right here on the page, from BNGO's filings and figures. One a day without an account; a free account has its own, and no card.
Cash flow breakdown
What the business generated, and where it went
Operating cash flow
−$16.35M 2025
Cash generated by the business itself
Free cash flow
−$38.31M 2020
Operating cash flow minus capital expenditure
Capital expenditure
$0 2020
Spending on property, plant and equipment
BNGO generated −$16.35M of operating cash flow. Each figure below is what it did with that, as reported on the same statement.
A non-cash cost, added back above
As reported in the company's own annual filings.
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | −$16.35M | −$68.92M | −$125.18M | −$124.82M | −$71.93M | −$38.31M | −$29.53M | −$19.94M | −$20.82M |
| Capital expenditure | - | - | - | - | - | $0 | $61.06K | $331.72K | $1.02M |
| Free cash flow | - | - | - | - | - |
Financial statements
Every figure below is this company’s, as filed. Measure draws them: 9 years and 38 quarters plotted to scale, on the income statement, balance sheet and cash flow, plus the ratio and estimate sections this page does not carry.
Free, no card, and it does not expire. See what the paid plans add
Gross profit
Plotted to scale onMeasure
Revenue
Plotted to scale onMeasure
As reported in the company's own annual filings.
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $28.51M | $30.78M | $36.12M | $27.8M | $17.98M | $8.5M | $10.13M | $12M | $9.51M |
| Cost of revenue | $15.32M | $30.4M | $26.55M | $21.86M | $14.11M | $5.73M | $6.77M | $8.71M | $6.03M |
| Gross profit | $13.19M | $380K | $9.57M | $5.95M | $3.87M |
Total assets
Plotted to scale onMeasure
Total liabilities
Plotted to scale onMeasure
Cash
Plotted to scale onMeasure
Current assets
Plotted to scale onMeasure
Current liabilities
Plotted to scale onMeasure
As reported in the company's own annual filings.
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | $73.58M | $76.67M | $214.4M | $307.5M | $377.1M | $60.45M | $30.21M | $24.8M | $10.15M |
| Current assets | $45.39M | $39.49M | $140.12M | $157.3M | $272.41M | $46.79M | $28.26M | $23.03M | $7.14M |
| Cash | $2.99M | $9.17M | $17.95M | $5.09M | $24.57M |
Derived from SEC XBRL filings. Not investment advice.
See every filed year for BNGO, quarter by quarter.
Ten seconds. No card. Nothing to cancel.
Be told the next time BNGO files
Watch BNGO and every quarterly and annual report, material 8-K, open-market Form 4 worth a row and tracked manager's change lands in the bell and a daily email. Free.
See all 9 filed years plotted, not just read
Every annual statement BNGO has filed is on this page as figures. Drawn to scale, a trend over the whole record is something you can see rather than something you have to add up.
The charts, to scaleMeasure
Catch a turn before the year confirms it
Revenue, margins and cash flow quarter by quarter, where a change in direction shows up first.
Quarterly statementsMeasure
Ask why a number moved, get the filing back
Why a margin moved, where the cash went: answered from BNGO's own statements, not a guess.
Free, no card, and it does not expire.
| −$38.31M |
| −$29.59M |
| −$20.28M |
| −$21.84M |
| Stock-based compensation | $4.53M | $9.74M | $15.18M | $22.42M | $9.72M | $1.55M | $1.35M | $1.19M | $382.83K |
|---|
| $2.77M |
| $3.36M |
| $3.29M |
| $3.47M |
| Research and development | $11.37M | $24.8M | $54.03M | $49.05M | $22.49M | $10.26M | $9.08M | $9.48M | $12.01M |
|---|
| Selling, general and administrative | $35.15M | $51.86M | $92.76M | $88.6M | $58.49M | $31.07M | $20.16M | $14.22M | $14.08M |
|---|
| Operating income | −$33.34M | −$103.98M | −$215.25M | −$131.7M | −$77.1M | −$38.55M | −$25.87M | −$20.42M | −$23.22M |
|---|
| Net income | −$26.4M | −$112.02M | −$232.49M | −$132.6M | −$72.44M | −$41.11M | −$29.82M | −$18.5M | −$23.37M |
|---|
| Diluted EPS | -$4.85 | -$88.13 | -$408.60 | -$4.58 | -$0.26 | - | - | - | - |
|---|
| Diluted shares | 5.45M | 1.27M | 569K | 28.92M | 276.78M | - | - | - | - |
|---|
| Gross margin | 46.25% | 1.23% | 26.49% | 21.38% | 21.54% | 32.61% | 33.18% | 27.41% | 36.55% |
|---|
| Operating margin | −116.95% | −337.87% | −595.98% | −473.70% | −428.79% | −453.38% | −255.44% | −170.12% | −244.28% |
|---|
| Net margin | −92.59% | −363.98% | −643.74% | −476.93% | −402.84% | −483.43% | −294.34% | −154.13% | −245.82% |
|---|
| $38.45M |
| $17.31M |
| $16.52M |
| $1.02M |
| Short-term investments | $16.28M | $302K | $48.82M | $108.1M | $226.04M | $0 | - | - | - |
|---|
| Total liabilities | $29.16M | $41.3M | $118.25M | $58.1M | $39.98M | $25.37M | $26.59M | $14.67M | $17.36M |
|---|
| Current liabilities | $22.94M | $37.34M | $100.03M | $35.88M | $21.84M | $8.95M | $26.37M | $4.52M | $16.65M |
|---|
| Total debt | - | - | - | - | $0 | $16.33M | $0 | $9.03M | $0 |
|---|
| Shareholder equity | $44.42M | $35.38M | $96.16M | $249.4M | $337.12M | $35.08M | $3.61M | $10.14M | −$50.23M |
|---|